The selective serotonin reuptake inhibitors controversy in the treatment of depression in children

Current Psychiatry Reports

Volumn 7, Issue 2, 2005, Pages 87-90

  Weller, Elizabeth B ^b   Tucker, Sheridan ^a   Weller, Ronald A ^a  

^a Children's Hospital of Philadelphia ^*

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADOLESCENT; ANXIETY DISORDER; CHILD; CHILD PSYCHIATRY; CLINICAL TRIAL; DEPRESSION; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INFORMATION; DRUG LABELING; DRUG PACKAGING; DRUG SAFETY; DRUG UTILIZATION; FAMILY HISTORY; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERACTIVITY; INSOMNIA; INTERPERSONAL COMMUNICATION; MANIA; MEDICAL DECISION MAKING; OBSERVATION; PANIC; PARENT COUNSELING; PRESCRIPTION; RESTLESSNESS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SUICIDAL BEHAVIOR; TREATMENT OUTCOME; VIOLENCE;

EID: 20444426189     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-005-0003-x     Document Type: Review

References (15)

1. Emminghaus H: Die Psychischen Storungen Des Kindesalters. Tubingen: Verlag der H. Laupp'schen Buchhandlung; 1887.
2. Lewis M, Ed: Child and Adolescent Psychiatry, A Comprehensive Textbook, 3rd Edition. Philadelphia: Lippincott Wilkins & Williams; 2002.
3. Olfson M, Marcus SC, Weissman MM, et al.: National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 2002, 41:514-521.
4. Shaffer D, Fisher P, Dulcan MK, et al.: The NIMH Diagnostic Interview Schedule, Version 2.3 (DISC-2.3): description, acceptability, prevalence rates and Performance of the MECA Study, Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry 1996, 35:865-877.
5. Harrington R, Bredenkamp D, Groothues C, et al.: Adult outcomes of child andadolescent depression, III: Links with suicidal behaviors. J Child Psychol Psychiatry 1994, 35:1309-1319.
6. Weller EB, Kang J, Weller RA: Clinical perspective on pediatric depression. Curr Psychiatry 2004, 3:12-23.
7. Vorstman J, Lahuis B, Buiteclaar JK: SSRIs associated with behavioral activation and suicidal ideation. J Am Acad Child Adol Psychiatry 2001, 40:1364-1365.
8. Whittington CJ, Kendall T, Fonagy P, et al.: Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet 2004, 363:1341-1345.
9. Current Problems in Pharmacovigilance: http://www.mhra.gov.uk.2003.
10. Labeling Change Request Letter for Antidepressant Medications: 2004. http://www.fda.gov/cder/drug/antidepressants/SSRIlabelChange.htm Accessed November 5, 2004.
11. FDA Proposed Mediation Guide: About Using Antidepressants in Children or Teenagers. http:/www.fda.gov/cder/drug/antidepressants/SSRIMedication.htm Accessed November 5, 2004.
12. Lish JD, Dime-Meenan S, Whybrow P, et al.: The National Depressive and Manic Depressive association (DMDA) survey of bipolar members. J Affec Disord 1994, 31:281-294.
13. Akiskal HS, Chen SE, Davis GC, et al.: Borderline: an adjective in search of a noun. J Clin Psychiatry 1984, 46:41-48.
14. Stahl SM: Essential Psychopharmacology. New York: Cambridge University Press; 2000.
15. Manji HK, Bowden CL, Belmaker RH: Bipolar Medications. Washington, DC: American Psychiatric Press; 2000.